Bullish Case: Moderate Buy consensus and institutional investment signal confidence in growth potential.


Show historical bullish cases

Bearish Case: Revenue decline and insider share sales indicate near-term headwinds.


Show historical bearish cases

Takeaway: Despite short-term challenges, RGEN is poised for long-term growth driven by its strong technology platform and industry partnerships. However, monitor revenue trends and insider activity closely.


Show historical takeaways

Potential Outcomes:

1) Continued revenue growth and new partnerships drive stock higher (50%): RGEN's innovative bioprocessing technology has significant long-term potential. The Sartorius partnership demonstrates this. 2) Insider sales and mixed quarterly results weigh on stock performance (30%): Declining revenue and insider sales signal near-term concerns. 3) Biotech sector downturn drags stock lower (20%): Broader negative biotech sentiment would likely impact RGEN.


September 27, 2023



Correlated Stock Forecasts

Assets that tend to move strongly with RGEN



ZION Forecast + Options Trading Strategies   [ZION]  Zions Bancorporation N.A (0.79)


MOS Forecast + Options Trading Strategies   [MOS]  Mosaic (0.75)


BOH Forecast + Options Trading Strategies   [BOH]  Bank of Hawaii (0.72)


USB Forecast + Options Trading Strategies   [USB]  U.S. Bancorp. (0.71)


EGY Forecast + Options Trading Strategies   [EGY]  VAALCO Energy (0.7)



Uncorrelated Stock Forecasts

Assets with little price relationship to RGEN



RSP Forecast + Options Trading Strategies   [RSP]  Invesco S&P 500 Equal Weight (-0.0)


CC Forecast + Options Trading Strategies   [CC]  Chemours (0.01)


XPRO Forecast + Options Trading Strategies   [XPRO]  Expro (-0.01)


FN Forecast + Options Trading Strategies   [FN]  Fabrinet (-0.01)


GFS Forecast + Options Trading Strategies   [GFS]  GlobalFoundries (0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against RGEN



NVS Forecast + Options Trading Strategies   [NVS]  Novartis (-0.61)


SNY Forecast + Options Trading Strategies   [SNY]  Sanofi (-0.63)


MCD Forecast + Options Trading Strategies   [MCD]  McDonald's (-0.64)


ISRG Forecast + Options Trading Strategies   [ISRG]  Intuitive Surgical (-0.66)


MDLZ Forecast + Options Trading Strategies   [MDLZ]  Mondelez International (-0.69)